These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6154203)

  • 1. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.
    Vandongen R; Margetts B; Beilin LJ; deKlerk N; Rogers P
    Eur J Clin Pharmacol; 1986; 30(3):283-7. PubMed ID: 2874032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
    Hansson BG
    Acta Med Scand Suppl; 1976; 598():1-61. PubMed ID: 13611
    [No Abstract]   [Full Text] [Related]  

  • 4. Excessive plasma dopamine increase at rest and during exercise after long-term beta-adrenoreceptor blockade in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    Br Heart J; 1980 Jul; 44(1):25-9. PubMed ID: 7426157
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.
    Kirsten R; Heintz B; Böhmer D; Nelson K; Roth S; Welzel D
    Br J Clin Pharmacol; 1982; 13(Suppl 2):397S-406S. PubMed ID: 6125192
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxygen uptake and plasma catecholamines during submaximal and maximal exercise after long-term beta-receptor blockade.
    Franz IW; Lohmann FW; Koch G
    Int J Sports Med; 1985 Aug; 6(4):202-6. PubMed ID: 2864323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
    Floras JS; Hassan MO; Jones JV; Sleight P
    J Am Coll Cardiol; 1985 Jul; 6(1):186-95. PubMed ID: 2861218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.
    Vandongen R; Margetts B; Deklerk N; Beilin LJ; Rogers P
    Br J Clin Pharmacol; 1986 Jun; 21(6):627-32. PubMed ID: 3741714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-adrenergic blockade on circulating catecholamines and dopamine-beta-hydroxylase activity during exercise in normal subjects.
    Sheehan MW; Brammell HL; Sable DL; Nies AS; Horwitz LD
    Am Heart J; 1983 May; 105(5):777-82. PubMed ID: 6303097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.
    Trap-Jensen J; Carlsen JE; Hartling OJ; Svendsen TL; Tangø M; Christensen NJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):391S-395S. PubMed ID: 6125191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta adrenergic blockade on plasma catecholamines in exercise.
    Irving MH; Britton BJ; Wood WG; Padgham C; Carruthers M
    Nature; 1974 Apr; 248(448):531-3. PubMed ID: 4150965
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W; Hausen M; Krämer B; Kübler W
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise.
    Koch G; Franz IW; Lohmann FW
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():433s-435s. PubMed ID: 6797778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.
    Koch G; Franz IW; Gubba A; Lohmann FW
    Acta Med Scand Suppl; 1983; 672():55-62. PubMed ID: 6138935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic beta-adrenoceptor antagonism on plasma catecholamines and blood pressure in hypertension.
    Watson RD; Eriksson BM; Hamilton CA; Reid JL; Stallard TJ; Littler WA
    J Cardiovasc Pharmacol; 1980; 2(6):725-38. PubMed ID: 6160323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac and metabolic beta-adrenergic receptor blockade by pindolol in man].
    Scheen A; Luyckx A; Juchmes J; Cession-Fossion A
    C R Seances Soc Biol Fil; 1977; 171(3):666-9. PubMed ID: 199324
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta receptor blockers on ergometric work in hypertensive patients.
    Franz IW; Lohmann FW; Rocker I; Kothari P
    Indian Heart J; 1979; 31(5):259-62. PubMed ID: 42612
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
    Hansson BG; Dymling JF; Hedeland H; Hulthén UL
    Eur J Clin Pharmacol; 1977 Apr; 11(4):239-45. PubMed ID: 324771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.